| abstract |
The present invention provides improved therapeutics and methods for the treatment of diseases associated with amyloid deposits of A [beta] in the brain of a patient. The method comprises administering an amyloid deposit deposit that has an agent that induces an advantageous immunogenic response. The method is useful for the prevention and treatment of Alzheimer's disease. Preferred are agents comprising an N-terminal fragment of Aβ and an antibody binding thereto. |